Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study aims to predict who needs surgery for severe colitis

NCT ID NCT03907631

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 189 adults hospitalized with acute severe ulcerative colitis to track their treatments and outcomes. Researchers will collect detailed medical data to identify factors that predict whether a patient needs stronger medications or emergency surgery. The goal is to help doctors make better decisions and potentially reduce the number of patients who need their colon removed.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better predict which patients need urgent surgery or stronger medications, potentially reducing colectomy rates.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly test new therapies. Results may take years to influence clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

189 people

The number who actually took part.

Started

Oct 2019

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Hospitalised patients with Acute severe ulcerative colitis

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age 18 - 80 years. * Confirmed acute severe ulcerative colitis based on modified Truelove and Witts criteria requiring hospital admission. * Need for at least 2 days of intravenous steroids * Able to sign consent Exclusion Criteria: * Crohn's disease * Admission for elective colectomy * Infective colitis confirmed on stool culture, assays for C. difficile or cytomegalovirus * Pregnancy * Inability to sign consent * Prior colitis related surgery - pouch, stoma

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Severe ulcerative colitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Gastroenterology, Hull Royal Infirmary, Hull University Teaaching Hospitals NHS Trust

    Hull, United Kingdom